Timothy Franson

Dr. Franson currently serves as a Principal in the Health and FDA Practice for Faegre Drinker Consulting. From 2014 until 2019, he served as the Chief Medical Officer of YourEncore, an advisory firm focused on global life sciences and consumer health companies. From 2009 until 2014, he was a Principal of FaegreBD Consulting, a clinical and regulatory pharmaceutical development consulting firm, which merged into Faegre Drinker in 2020. In 2008, Dr. Franson founded and served as President of Franson Pharma Advisors LLC, a clinical and regulatory pharmaceutical development consulting firm. Between 1986 and 2008, Dr. Franson held various senior leadership positions at Eli Lilly and Company. At the time of his retirement, he served as Vice President of Global Regulatory Affairs at Lilly Research Laboratories, an Eli Lilly subsidiary. Dr. Franson is integrally involved in global public health initiatives through the U.S. Pharmacopeial Convention (USP), currently serving as the immediate past President of this organization and on the USP Board of Trustees since 2010. He serves on the Board of Directors of Paratek Pharmaceuticals and as the Board Chair for the Critical Path Institute, which collaborates with FDA and industry in innovation advances. Dr. Franson has authored more than 50 articles in the fields of infectious disease, epidemiology, pharmacoeconomics and antibiotic utilization. He holds a B.S. in Pharmacy from Drake University and an M.D. from the University of Illinois College of Medicine. He is board certified in Internal Medicine and Infectious Diseases and is an Adjunct Professor of Medicine at Indiana University School of Medicine.